Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in J Gastroenterol

Retrieve available abstracts of 43 articles:
HTML format

Single Articles

    May 2024
  1. HOKKOKU D, Sasaki K, Kobayashi S, Shimbo T, et al
    High-mobility group box 1 fragment ameliorates chronic pancreatitis induced by caerulein in mice.
    J Gastroenterol. 2024 May 10. doi: 10.1007/s00535-024-02112.
    PubMed     Abstract available

    April 2024
  2. MATSUMOTO K, Fujimori N, Ichihara K, Takeno A, et al
    Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction.
    J Gastroenterol. 2024 Apr 29. doi: 10.1007/s00535-024-02103.
    PubMed     Abstract available

    February 2024
  3. NAGAO K, Sakai A, Tsumura H, Iemoto T, et al
    Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy.
    J Gastroenterol. 2024 Feb 29. doi: 10.1007/s00535-024-02083.
    PubMed     Abstract available

    January 2024
  4. KASHIRO A, Kobayashi M, Oh T, Miyamoto M, et al
    Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer.
    J Gastroenterol. 2024 Jan 23. doi: 10.1007/s00535-023-02072.
    PubMed     Abstract available

  5. ABE S, Masuda A, Matsumoto T, Inoue J, et al
    Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma.
    J Gastroenterol. 2024 Jan 20. doi: 10.1007/s00535-023-02069.
    PubMed     Abstract available

    November 2023
  6. SAKAKIDA T, Ishikawa T, Doi T, Morita R, et al
    Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database.
    J Gastroenterol. 2023 Nov 25. doi: 10.1007/s00535-023-02058.
    PubMed     Abstract available

  7. TAKEUCHI C, Sato J, Yamamichi N, Kageyama-Yahara N, et al
    Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation.
    J Gastroenterol. 2023 Nov 14. doi: 10.1007/s00535-023-02055.
    PubMed     Abstract available

    September 2023
  8. OZONO Y, Kawakami H, Uchiyama N, Hatada H, et al
    Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary-pancreatic cancers.
    J Gastroenterol. 2023 Sep 12. doi: 10.1007/s00535-023-02037.
    PubMed     Abstract available

  9. OKUSAKA T, Saiura A, Shimada K, Ikeda M, et al
    Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort.
    J Gastroenterol. 2023 Sep 7. doi: 10.1007/s00535-023-02033.
    PubMed     Abstract available

    August 2023
  10. FISCHMAN M, Elias A, Klein A, Cohen Y, et al
    The association between phosphate level at admission and early mortality in acute pancreatitis.
    J Gastroenterol. 2023 Aug 18. doi: 10.1007/s00535-023-02034.
    PubMed     Abstract available

    July 2023
  11. OYAMA H, Hamada T, Nakai Y, Tanaka M, et al
    Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases.
    J Gastroenterol. 2023 Jul 29. doi: 10.1007/s00535-023-02028.
    PubMed     Abstract available

  12. ASHINA S, Masuda A, Yamakawa K, Hamada T, et al
    A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma.
    J Gastroenterol. 2023 Jul 21. doi: 10.1007/s00535-023-02020.
    PubMed     Abstract available

    June 2023
  13. TOMIMARU Y, Eguchi H, Shimomura Y, Kitamura T, et al
    Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society.
    J Gastroenterol. 2023 Jun 17. doi: 10.1007/s00535-023-01988.
    PubMed     Abstract available

    May 2023
  14. KAWASAKI Y, Hijioka S, Nagashio Y, Maruki Y, et al
    Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation.
    J Gastroenterol. 2023 May 8. doi: 10.1007/s00535-023-01995.
    PubMed     Abstract available

    April 2023
  15. SAKAI A, Masuda A, Kodama Y
    Does early intervention for infected pancreatic necrosis lead to better clinical outcomes compared to delayed intervention?
    J Gastroenterol. 2023 Apr 30. doi: 10.1007/s00535-023-01994.

  16. MURAKAMI M, Fujimori N, Nakata K, Nakamura M, et al
    Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
    J Gastroenterol. 2023 Apr 26. doi: 10.1007/s00535-023-01987.
    PubMed     Abstract available

  17. SAKAKIDA T, Ishikawa T, Doi T, Morita R, et al
    Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan.
    J Gastroenterol. 2023 Apr 7. doi: 10.1007/s00535-023-01986.
    PubMed     Abstract available

    January 2023
  18. TANAKA T, Masuda A, Inoue J, Hamada T, et al
    Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma.
    J Gastroenterol. 2023 Jan 27. doi: 10.1007/s00535-022-01939.
    PubMed     Abstract available

    December 2022
  19. SATAKE T, Morizane C, Rikitake R, Higashi T, et al
    Correction: The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.
    J Gastroenterol. 2022 Dec 23. doi: 10.1007/s00535-022-01944.

    November 2022
  20. IWASHITA T, Iwata K, Hamada T, Saito T, et al
    Supportive treatment during the periprocedural period of endoscopic treatment for pancreatic fluid collections: a critical review of current knowledge and future perspectives.
    J Gastroenterol. 2022 Nov 7. pii: 10.1007/s00535-022-01935.
    PubMed     Abstract available

    October 2022
  21. HISADA Y, Hijioka S, Ikeda G, Maehara K, et al
    Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide NCC Oncopanel System analysis suitability criteria: a single-arm, phase II clinical trial.
    J Gastroenterol. 2022 Oct 3. pii: 10.1007/s00535-022-01926.
    PubMed     Abstract available

    September 2022
  22. SATAKE T, Morizane C, Rikitake R, Higashi T, et al
    The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.
    J Gastroenterol. 2022 Sep 26. pii: 10.1007/s00535-022-01920.
    PubMed     Abstract available

  23. KAWAKUBO K, Fernandez-Del Castillo C, Liss AS
    Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy.
    J Gastroenterol. 2022 Sep 17. pii: 10.1007/s00535-022-01922.

  24. KAWAKUBO K, Castillo CF, Liss AS
    Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy.
    J Gastroenterol. 2022 Sep 1. pii: 10.1007/s00535-022-01915.
    PubMed     Abstract available

    August 2022
  25. SHIMIZU K, Ito T, Irisawa A, Ohtsuka T, et al
    Evidence-based clinical practice guidelines for chronic pancreatitis 2021.
    J Gastroenterol. 2022 Aug 22. pii: 10.1007/s00535-022-01911.
    PubMed     Abstract available

  26. UCHIDA K, Okazaki K
    Current status of type 1 (IgG4-related) autoimmune pancreatitis.
    J Gastroenterol. 2022 Aug 2. pii: 10.1007/s00535-022-01891.
    PubMed     Abstract available

    July 2022
  27. KANDA T, Wakiya T, Ishido K, Kimura N, et al
    Heterogeneity of metabolic adaptive capacity affects the prognosis among pancreatic ductal adenocarcinomas.
    J Gastroenterol. 2022 Jul 3. pii: 10.1007/s00535-022-01898.
    PubMed     Abstract available

    June 2022
  28. YAMAMOTO K, Iwadate D, Kato H, Nakai Y, et al
    Targeting autophagy as a therapeutic strategy against pancreatic cancer.
    J Gastroenterol. 2022 Jun 21. pii: 10.1007/s00535-022-01889.
    PubMed     Abstract available

  29. OKADA Y, Nakasone H, Nakamura Y, Kawamura M, et al
    Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation.
    J Gastroenterol. 2022 Jun 3. pii: 10.1007/s00535-022-01881.
    PubMed     Abstract available

    April 2022
  30. GAO L, Zhang H, Li G, Ye B, et al
    The clinical outcome from early versus delayed minimally invasive intervention for infected pancreatic necrosis: a systematic review and meta-analysis.
    J Gastroenterol. 2022 Apr 29. pii: 10.1007/s00535-022-01876.
    PubMed     Abstract available

    February 2022
  31. OKAZAKI K, Kawa S, Kamisawa T, Ikeura T, et al
    Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020.
    J Gastroenterol. 2022 Feb 22. pii: 10.1007/s00535-022-01857.
    PubMed     Abstract available

    January 2022
  32. KAWABATA H, Ono Y, Tamamura N, Oyama K, et al
    Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway.
    J Gastroenterol. 2022 Jan 11. pii: 10.1007/s00535-021-01846.
    PubMed     Abstract available

    August 2021
  33. CAO Z, Qiu J, Guo J, Xiong G, et al
    A randomised, multicentre trial of somatostatin to prevent clinically relevant postoperative pancreatic fistula in intermediate-risk patients after pancreaticoduodenectomy.
    J Gastroenterol. 2021 Aug 28. pii: 10.1007/s00535-021-01818.
    PubMed     Abstract available

  34. MASAKI Y, Nakase H, Tsuji Y, Nojima M, et al
    The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis.
    J Gastroenterol. 2021 Aug 24. pii: 10.1007/s00535-021-01817.
    PubMed     Abstract available

    July 2021
  35. CANNON A, Thompson CM, Bhatia R, Armstrong KA, et al
    Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma.
    J Gastroenterol. 2021 Jul 19. pii: 10.1007/s00535-021-01800.
    PubMed     Abstract available

    A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer.
    J Gastroenterol. 2021 Jul 13. pii: 10.1007/s00535-021-01806.
    PubMed     Abstract available

    June 2021
  37. KURIYAMA K, Kodama Y, Shiokawa M, Nishikawa Y, et al
    Essential role of Notch/Hes1 signaling in postnatal pancreatic exocrine development.
    J Gastroenterol. 2021 Jun 14. pii: 10.1007/s00535-021-01779.
    PubMed     Abstract available

    March 2021
  38. WANG WQ, Zhang WH, Gao HL, Huang D, et al
    A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors.
    J Gastroenterol. 2021 Mar 19. pii: 10.1007/s00535-021-01777.
    PubMed     Abstract available

    February 2021
  39. LAI SW
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 5. pii: 10.1007/s00535-021-01764.

  40. BRUSSELAERS N, Sadr-Azodi O, Engstrand L
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 2. pii: 10.1007/s00535-021-01761.

    October 2020
  41. SAKAI A, Masuda A, Eguchi T, Anami T, et al
    Clinical outcome of conservatively managed pancreatic intraductal papillary mucinous neoplasms with mural nodules and main duct dilation.
    J Gastroenterol. 2020 Oct 28. pii: 10.1007/s00535-020-01739.
    PubMed     Abstract available

  42. TEZUKA K, Okamura Y, Sugiura T, Ito T, et al
    The influence of familial pancreatic cancer on postoperative outcome in pancreatic cancer: relevance to adjuvant chemotherapy.
    J Gastroenterol. 2020 Oct 22. pii: 10.1007/s00535-020-01730.
    PubMed     Abstract available

    August 2019
  43. HAKUTA R, Hamada T, Nakai Y, Oyama H, et al
    Natural history of asymptomatic bile duct stones and association of endoscopic treatment with clinical outcomes.
    J Gastroenterol. 2019 Aug 31. pii: 10.1007/s00535-019-01612.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.